Definium Therapeutics Highlights DT120 ODT (Lysergide Tartrate) Clinical Advancements and Commercial Strategy at Investor and Analyst Day April 23, 2026 mental-health ONLY AVAILABLE IN PAID PLANS. Originally reported by rutlandherald. Read more Source: https://www.rutlandherald.com/news/business/definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advancements-and-commercial-strategy-at-investor-and/article_4f963fb3-0c70-51cd-acc7-9ea7d95d890a.html
